Submitted by Anonymous (not verified) on 25 February 2026 - 14:01
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 12, Status: Authorised